NAD+ administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia

2012 ◽  
Vol 512 (2) ◽  
pp. 67-71 ◽  
Author(s):  
Chaobo Zheng ◽  
Jin Han ◽  
Weiliang Xia ◽  
Shengtao Shi ◽  
Jianrong Liu ◽  
...  
2018 ◽  
Vol 45 (2) ◽  
pp. 458-473 ◽  
Author(s):  
Li-Qun Sun ◽  
Gong-Liang Guo ◽  
Sai Zhang ◽  
Li-Li  Yang

Background/Aims: This study aimed to explore the effect of microRNA-592-5p (miR-592-5p) on hypoxic-ischemic brain damage (HIBD)-induced hippocampal neuronal injury in a neonatal mouse model relative to the involvement of one target gene, PTGDR, and the PGD2/ DP signaling pathway. Methods: A total of 30 neonatal mice aged 7 days were randomly selected to establish an HIBD mouse model. Hippocampal neuronal cells were transfected into a control group, a blank group, a negative control (NC) group, an miR-592-5p mimics group, an miR-592-5p inhibitors group, an siRNA-PTGDR group and an miR-592-5p inhibitors + siRNA-PTGDR group. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot analyses were performed to detect the expression levels of miR-592-5p, PTGDR, DP2, Bcl-2 and Bax in tissues and cells. Cell proliferation, cell cycle and apoptosis were detected by MTT assay and flow cytometry, respectively. Results: The expression levels of miR-592-5p and Bcl-2 decreased, while the expression levels of PTGDR, DP2 and Bax increased in the HIBD group. PTGDR is a target gene of miR-592-2p. Compared with the NC and blank groups, the expression levels of PTGDR, DP2 and Bax decreased, while the expression levels of miR-592-5p and Bcl-2 increased in the miR-592-5p mimics group. The siRNA-PTGDR group showed the same trend as that observed in the miR-592-5p mimics group, except with no difference in miR-592-5p expression. The miR-592-5p inhibitors group showed an opposite gene expression trend compared to that in the miR-592-5p mimics group. The S phase of the cell cycle was prolonged, the G1 phase was reduced, proliferation was increased, and the apoptosis rate was decreased in the siRNA-PTGDR and miR-592-5p mimics groups. Opposite trends for cell cycle, proliferation and apoptosis were observed in the miR-592-5p inhibitors group. Conclusions: Our study suggests that miR-592-5p upregulation protects against hippocampal neuronal injury caused by HIBD by targeting PTGDR and inhibiting the PGD2/DP signaling pathway.


2019 ◽  
Vol 5 (3) ◽  
pp. 152
Author(s):  
Xuxin Ren ◽  
Qiaoli Ren ◽  
Yilin Liu ◽  
Wenyan Zhao ◽  
Wei Liu ◽  
...  

2013 ◽  
Vol 8 (S 01) ◽  
Author(s):  
V Darsalia ◽  
A Olverling ◽  
H Ortsäter ◽  
T Klein ◽  
Å Sjöholm ◽  
...  

Biomeditsina ◽  
2019 ◽  
pp. 41-48
Author(s):  
E. V. Gantsgorn ◽  
D. P. Khloponin ◽  
P. A. Khloponin ◽  
Yu. S. Maklyakov

The cerebroprotective activity of nootropics in combination with melaxen (melatonin containing drug) was investigated by a comprehensive morphological analysis using an experimental model of acute cerebral ischemia in rats. According to the obtained data, a preventive use of vinpocetine in combination with melaxen signifi cantly reduces the degree of lethality among experimental animals and the severity of ischemic brain damage. A suggestion is made about the potential feasibility of melatonin-containing drugs for increasing the effi cacy of neuroprotection in cerebral ischemia.


2013 ◽  
Vol 183 (3) ◽  
pp. 1010-1024 ◽  
Author(s):  
Ganta V. Chaitanya ◽  
Walter E. Cromer ◽  
Courtney P. Parker ◽  
Pierre O. Couraud ◽  
Ignacio A. Romero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document